aeon secures €10M Seed, for preventive healthcare with whole-body MRIs

Quick Facts🗂️

• Company: Aeon Life
• Website: https://aeon.life/
• Location: Zurich, Switzerland
• Funding Round: Seed
• Amount Raised: €10M 
• Lead Investor(s): Concentric
• Other Investors: Calm/Storm, GoHub, Kadmos, EWOR, Daniel Gutenberg
• All Investors: Calm/Storm, Concentric, Daniel Gutenberg, EWOR, GoHub, Kadmos
• Total Funding to Date: €9 million
• Founded: 2023
• Sector: HealthTech / Preventive Medicine

Company Overview🗞️

Aeon Life is a Swiss-based startup developing an AI-powered preventive health platform that integrates whole-body MRI, blood biomarker analysis, and genetic testing. The company’s core offering is a 60-minute, multi-modal health check-up designed to screen for over 500 diseases and conditions. Aeon is seeking to address the critical consequences of late diagnosis and unneeded medical interventions by leveraging AI to minimize false positives and generate personalized risk profiles for individuals.

Founders: Tim Seithe (CEO), Samuel Frey (CPO)

Team Size: 9 

Funding Round Details💶

On June 4, 2025, Aeon announced a $9 million Seed round led by Concentric, with participation from Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, EWOR, and Swiss super angel investor Daniel Gutenberg.

According to Tim Seithe, the funds will be used to:

• Expand across Switzerland, Germany, and the UK
• Build partnerships with insurers and employers
• Enhance its AI platform for faster and more precise diagnostics
• Open 10+  new clinic locations in the coming months

Market and Differentiation🌐

Aeon operates in the preventive healthcare and diagnostics market, which is estimated to reach $349B by 2030. Aeon’s data-driven approach of integrating full-body MRI, advanced blood biomarkers, and genetic data into one check-up positions it to capitalize on this growing market by delivering:

• Multi-modal health assessments offering a holistic view of health, surpassing standard check-ups that typically rely on limited screening methods.
• A system that provides rapid, radiation-free, full-body imaging that covers internal organs, the brain, and the skeletal and vascular systems, differentiating it from many competitors who focus on single-organ scans or utilize ionizing radiation.
• A platform that provides quick and precise results with personalized recommendations, making proactive health management accessible and actionable for individuals beyond traditional high-risk or symptomatic patient profiles.

DIRECT COMPETITORS

Neko Health (Sweden, €330M)

• Description: Developer of medical scanning systems focused on early disease detection and preventive care. The platform combines advanced sensor technology with AI to support early diagnosis and help reduce the overall burden and cost of common health conditions.
• Aeon Life’s Differentiation: Aeon Life’s platform combines whole-body MRI with comprehensive blood tests and optional DEXA scans. Aeon Life thus differs significantly from Neko Health, which relies on sensor-based body scanning without MRI technology.

Prenuvo (Canada, $190M)

• Description: Developer of an MRI based platform designed to enhance the precision and reproducibility of diagnostics. The platform enables multiparametric MRI methods to assess a range of conditions affecting the brain, cancer sites, thoracic region, abdomen, liver, reproductive system, and spine. It is utilized by clinicians and pharmaceutical researchers for the early identification of diseases, offering a cost-efficient diagnostic solution.
• Aeon Life’s Differentiation: Aeon Life integrates blood analysis and optional DEXA scans with whole-body MRI in a single appointment, delivering a more comprehensive, multimodal preventive health check, while Prenuvo focuses exclusively on advanced whole-body MRI imaging without blood analysis or DEXA scans.

Ezra Scan (USA, $43M raised, then acquired by Function Health)

• Description: Developer of cancer screening technology aimed at facilitating early detection through accessible and cost-effective solutions. The equipment incorporates AI to aid in conducting MRI scans, which are evaluated by radiologists during a single session to screen for prostate cancer. This method enhances both the accuracy and efficiency of diagnosis.
• Aeon Life’s Differentiation: Aeon Life’s platform combines full-body MRI, blood analysis, and optional DEXA scans to detect a broader range of conditions in one visit. It also offers group-based services and fast digital results. In contrast, Ezra focuses primarily on MRI-based early cancer detection, not including routine blood tests or additional diagnostics.

simonONE (US, by SimonMed – owned by American Securities)

• Description: Developer of a full-body MRI screening platform that aims to identify cancer and other prevalent health conditions before the onset of symptoms. The process utilizes advanced MRI technology, with select scans incorporating FDA-cleared AI tools. Each scan is analyzed by qualified radiologists. The procedure is noninvasive, free of radiation, and typically lasts between 15 to 45 minutes.
• Aeon Life’s Differentiation: Aeon Life’s platform offers a combined whole-body MRI and blood analysis as a core part of its check-up, providing a more comprehensive preventive health screening solution in a single visit, whereas SimonONE focuses on full-body MRI scans alone.

INDIRECT COMPETITORS 

AI-Powered Medical Imaging Companies (Icometrix) (Belgium, €22M)

• Description: Developer of an AI-enabled software tailored to analyzing brain MRI scans. The platform operates via the cloud and is capable of extracting clinically relevant data from both brain MRI and CT images of individuals with neurological conditions. This tool is intended to support healthcare providers by streamlining the diagnosis and ongoing assessment of multiple sclerosis.
• Aeon Life’s Differentiation: Aeon Life’s platform seeks to provide a holistic and multi-modal diagnostic platform that includes data from MRIs, blood biomarker analysis, and genetic testing. In contrast Icometrix is an AI powered software designed specifically for analyzing brain MRI scans.

Preventive Healthcare Platforms (Bionic Health) (USA, $3M)

• Description: Developer of a digital health platform focused on expanding preventative care solutions for individuals managing chronic pain. The platform emphasizes ongoing diagnostic evaluations and applies machine learning to generate individualized treatment strategies aimed at decelerating the aging process. Patients receive tailored insights derived from continuous data analysis and benefit from year-round, closely supervised preventative care.
• Aeon Life’s Differentiation: Aeon Life differentiates itself by offering a one-stop, imaging-led preventive health check focused on early disease detection, whereas Bionic Health provides a continuous, holistic, and personalized wellness program centered on long-term optimization and lifestyle management. Furthermore, Bionic Health’s platform is specifically designed to help patients combat chronic pain and decelerate the aging process. 

Digital Health and Telemedicine Companies (Ro) (USA, $1B)

• Description:  Provider of a direct-to-consumer telehealth solution designed to offer comprehensive care from initial diagnosis through at-home medication delivery. The platform connects users with licensed physicians and delivers full-service treatment pathways, including options for managing erectile dysfunction and smoking cessation. It also offers personalized care plans and complimentary delivery of prescribed medications.
• Aeon Life’s Differentiation: Aeon Life’s value proposition is significantly different from that of Ro. Aeon Life’s platform is a software-centric platform designed to provide multi-modal health assessments, whereas Ro is a telehealth platform that integrates telemedicine, pharmacy distribution, diagnostics, and in-home care services.

Wearable Health Technology (Oura) (Finland, €350M)

• Description: Developer of a wellness-focused wearable ring designed to monitor and enhance sleep quality and physical performance. The device tracks overall sleep quality, heart rate variability, and overnight body temperature by detecting changes in blood pulse volume. Using a data-driven system, it helps users improve sleep and general health by aligning with their natural circadian rhythm.
• Aeon Life’s Differentiation: While somewhat overlapping in market focus, Aeon Life differs significantly from Oura. Namely, Aeon Life is a diagnostic platform, whereas Oura is a consumer wearable that continuously tracks daily biometrics for ongoing wellness and lifestyle optimization.

Traditional Health Screening Services

• Description:

–Traditional Medical Centers: Diagnose and treat illnesses using evidence-based medicine, pharmaceuticals, surgery, and a wide range of healthcare services.

-Specialized Diagnostic Centers: Focus on providing advanced imaging and laboratory testing to support accurate and timely diagnosis. 

• Aeon Life’s Differentiation: Aeon’s software-driven platform provides an integrated approach to early health risk detection, utilizing MRI, and blood and genetic analysis. This contrasts with traditional and specialized centers that typically address illnesses post-symptom onset or offer fragmented diagnostics. Ultimately, these established centers may integrate Aeon’s technology to augment their diagnostic services.

Investor Insight🎙️

Alex Stroud, Principal at Concentric,commented:

“Aeon is not just another testing solution. Validated by insurers, Aeon is delivering the most medically robust preventive health product on the market. That rare combination of clinical rigor and commercial scalability is what makes this team so exciting.”

Why This Matters❗️

Recent investment in Aeon underscores the increasing interest in AI-powered healthcare, with AI-driven startups capturing 42% of global digital health funding in 2024. This trend is largely a response to mounting pressures on healthcare systems, including aging populations, clinician shortages, and burnout. Aeon is strategically poised to lead the shift toward proactive, AI-enabled preventive medicine. Its platform not only enhances diagnostic accuracy but also minimizes false positives and administrative overhead, allowing physicians greater focus on patient care. By integrating clinical-grade diagnostics with insurer-backed reimbursement, Aeon could establish a new benchmark for accessible, high-impact preventive healthcare.

Sources🔗

https://aeon.life/, https://www.linkedin.com/company/aeon-life/